Lv1
98 积分 2024-10-31 加入
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders
17小时前
已完结
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
6天前
已完结
Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8+ T cells
3个月前
已完结
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor
5个月前
已完结
下调BECN1抑制人白血病细胞系THP-1增殖、侵袭和迁移
5个月前
已关闭
Design, synthesis and structure-activity relationship studies of pyrido[2,3-d]pyrimidin-7-ones as potent Janus Kinase 3 (JAK3) covalent inhibitors
5个月前
已完结
The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells
5个月前
已完结
CAR T therapy beyond cancer: the evolution of a living drug
6个月前
已完结
The next-generation CAR-T therapy landscape
7个月前
已完结
Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-carboxamide Pseudokinase Domain Ligands as Highly Selective Inhibitors of Tyrosine Kinase 2 (TYK2)
8个月前
已完结
皖公网安备34019202002308
